ZNF282 Activators are a collection of chemical entities that indirectly amplify the functional activity of ZNF282 through a variety of cellular and molecular mechanisms. Forskolin boosts intracellular cAMP levels, indirectly bolstering ZNF282 function by triggering protein kinase A (PKA), which may phosphorylate transcription factors involved in ZNF282's activity. Similarly, Retinoic acid operates through nuclear receptors to potentially enhance ZNF282's role by modulating gene expression networks involving ZNF282-regulated genes. Histone deacetylase inhibitors like Trichostatin A and Sodium butyrate can facilitate ZNF282's transcriptional activation by increasing chromatin accessibility. The DNA methylation landscape alteration by 5-Azacytidine could upregulate genes interacting with ZNF282, thereby enhancing its function.
Furthermore, the activation of protein kinase C (PKC) by Phorbol 12-myristate 13-acetate (PMA) and modulation of G-protein coupled receptor pathways by Sphingosine-1-phosphate may lead to post-translational modifications that enhance ZNF282 activity. Epigallocatechin gallate (EGCG) and Roscovitine, as kinase inhibitors, could indirectly promote ZNF282's regulatory role by affecting the kinase-mediated phosphorylation milieu that influences ZNF282 and its associated transcriptional programs.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate various substrates including transcription factors that may enhance the DNA-binding activity of ZNF282, leading to its functional activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its nuclear receptors, which can modulate gene expression. This compound may enhance ZNF282 activity by influencing gene regulatory networks that include genes bound by ZNF282, thus indirectly enhancing its functional role in transcriptional regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that leads to a more relaxed chromatin structure, potentially increasing access for transcription factors like ZNF282 to their target DNA sequences, thereby enhancing ZNF282's transcriptional activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. By reducing DNA methylation, it may increase the expression of genes that are targets of ZNF282 or genes that encode regulators of ZNF282, enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate signaling pathways that intersect with gene expression regulation, potentially enhancing ZNF282 activity through phosphorylation of proteins that interact with or regulate ZNF282 function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that might enhance ZNF282 activity by inhibiting kinases that phosphorylate proteins interacting with ZNF282, thus modulating its function in the regulation of gene expression. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts through G-protein coupled receptors to influence cellular signaling pathways. It may enhance ZNF282 activity by activating signaling pathways that lead to the post-translational modifications of ZNF282 or its co-regulators. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as a histone deacetylase inhibitor, may enhance ZNF282 activity by increasing histone acetylation and thereby promoting a more accessible chromatin state for ZNF282 to bind and regulate gene expression. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase inhibitor that could enhance ZNF282 activity by altering the cell cycle, which may influence the transcriptional programs ZNF282 is involved in, thus impacting its functional role in gene regulation. | ||||||